Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 283609011000036114 | levodopa + benserazide | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 283610011000036117 | benserazide + levodopa (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| levodopa + benserazide | Is a | medicinal product | true | Inferred relationship | Some | ||
| levodopa + benserazide | has intended active ingredient | benserazide | true | Inferred relationship | Some | 1 | |
| levodopa + benserazide | has intended active ingredient | levodopa | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| levodopa 50 mg + benserazide 12.5 mg capsule | Is a | True | levodopa + benserazide | Inferred relationship | Some | |
| levodopa 100 mg + benserazide 25 mg capsule | Is a | True | levodopa + benserazide | Inferred relationship | Some | |
| levodopa 200 mg + benserazide 50 mg capsule | Is a | True | levodopa + benserazide | Inferred relationship | Some | |
| levodopa 200 mg + benserazide 50 mg tablet | Is a | True | levodopa + benserazide | Inferred relationship | Some | |
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | Is a | True | levodopa + benserazide | Inferred relationship | Some | |
| levodopa 100 mg + benserazide 25 mg tablet | Is a | True | levodopa + benserazide | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
Medicinal product reference set
FHIR